Physician profile
John C Britt
NPI 1871573121
$4,392.41
in general payments reported to CMS, 2019-2025
16 companies · $472 in 2025
The $472 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,671 · 2020: $49.40 · 2021: $70.79 · 2022: $936 · 2023: $94.02 · 2024: $99.07 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $664.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $2,615.58 | 2019 | |
| Exactech, INC. | $723.35 | 2022 | |
| Genzyme Corporation | $218.35 | 2021-2025 | |
| Optinose US, INC. | $198.14 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $141.68 | 2025 | Dupixent |
| Inspire Medical Systems, INC. | $122.22 | 2025 | Inspire |
| Aerin Medical INC. | $109.13 | 2025 | |
| Masimo Corporation | $95.56 | 2022-2025 | Set and Rainbow Set |
| Merck Sharp & Dohme LLC | $29.85 | 2025 | Keytruda, Keytruda Qlex |
| Stryker Corporation | $28.67 | 2021 | |
| Karl Storz Endoscopy-America | $27.57 | 2019 | |
| Aytu Biopharma, INC. | $22.25 | 2023 | Karbinal |
| Glaxosmithkline, LLC. | $21.64 | 2025 | Nucala |
| Alk-Abello, INC | $20.50 | 2020 | |
| Integra Lifesciences Corporation | $15.11 | 2024 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $2.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Britt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.